Encoraf 75 mg (Encorafenib) is a targeted BRAF inhibitor indicated for certain cancers with BRAF V600 mutations, including melanoma and metastatic colorectal cancer. It interferes with abnormal signaling pathways that drive tumor growth. Genetic testing is required before treatment, and therapy should be supervised by a healthcare professional. https://oncologymedi.com/product/encoraf-75-mg-encorafenib/